Pharmaceutical Company Charged Following Baby Deaths – UK Police

What a concept - holding pharmaceutical companies

responsible for what they produce!

© Srdjan Zivulovic / Reuters

Pharmaceutical company ITH Pharma Ltd is facing criminal prosecution following the deaths of babies at several British hospitals, police have announced.

London-based ITH Pharma Ltd is facing criminal charges after allegedly supplying contaminated feed to premature babies between May 27 and June 2, 2014.

The charges come after an investigation was launched in 2014, after three babies died and another 20 needed treatment over contracting septicemia (blood poisoning).  

Scotland Yard said in a statement on Wednesday: “ITH Pharma Ltd, based at Premier Park, NW10, has been charged with seven counts of supplying a medicinal product which was not of the nature or quality specified in the prescription on 27 May 2014.

“It has also been charged with failing to take all reasonably practicable steps to ensure that patients were not infected by contaminants, in breach of the Health and Safety at Work Act, between 1 August 2009 and 1 June 2014.

“The company is due to appear at Westminster Magistrates' Court on Monday, 17 December.”

The babies who died were treated at two hospitals: St Thomas' in London and Rosie Maternity Hospital, Cambridge.

Yousef Al-Kharboush died at only nine days old on June 1, 2014 after receiving the contaminated feed at St Thomas’. His parents said they will never recover from what happened.

“We have found it impossible to move on while the case is ongoing, I am not sure that we will ever come to terms with what happened,” his father, Raaid Sakkijha, said. 

Viagra Trial Baby Deaths: Dutch Research Project Called Off as 11 Infants Die

Did Viagra given to pregnant women cause Pulmonary Hypertension in babies?

© Mark Blinch / Reuters

A Dutch medical trial has been halted after the deaths of 11 babies whose mothers were given Viagra as part of a study aimed at helping unborn infants grow.

The research, led by Amsterdam University Medical Center, focused on improving the flow of blood through the placentas of 93 pregnant women. Since the trial ended, some 17 babies have developed lung problems and 11 have died, leading to fears that babies suffered fatal effects from the medication. Between 10-15 women are now waiting to hear if their child was also affected.

“We wanted to show that this is an effective way to promote the growth of the baby. But the opposite happened. I am shocked. The last thing you want is to harm patients,” gynecologist and leader of the research Wessel Ganzevoort told Dutch newspaper De Volkskrant.

Ganzevoort said her team have notified a group of Canadian researchers carrying out a similar study to warn them of the results. That research has now been temporarily stopped, she said.

During the study, 93 women in 10 hospitals across the Netherlands were given sildenafil, a medication sold as Viagra, the erectile dysfunction drug for men. Viagra dilates the blood vessels and is sometimes prescribed for people with high blood pressure. Researchers had hoped to improve the flow of blood through women’s placentas with the drug after seeing some good results in experimental research on rats.

Prior to the experiments, the growth of each of the unborn babies was found to be limited and the prognosis viewed as poor. The study was started in 2015 and was due to run until 2020, with 350 patients participating. It’s feared that the drug caused blood pressure to build up in the lungs, meaning the babies received a diminishing amount of oxygen.

Elevated blood pressure in the lungs is a form of Pulmonary Hypertension. That it has already claimed 11 of 17 babies would indicate that it is an intense form of PH. 

In a statement, Amsterdam UMC said that it believed the trial had been conducted properly, but will launch an external investigation to find the cause of deaths. All participants in the trial have now been informed whether they were given the drug or a placebo.

“An interim analysis by Amsterdam UMC, location AMC, showed that sildenafil may be detrimental to the baby after birth. The chance of a disease of the blood vessels of the lungs appears to be greater and the chance of death after birth seems to have increased,” the statement read. RT has contacted Amsterdam UMC for comment.

Ganzevoort expressed concern that doctors may have been prescribing the medication to pregnant women after hearing anecdotal evidence it may be good for children at medical conferences. “It was buzzing at conferences. Foreign colleagues let slip that they sometimes prescribed it, with good results,” she said.

“I have experienced in my own consulting room that pregnant women asked for it. Whether they have ordered it via the internet? I do not know. Who can know?”

Makes one wonder if Pfizer was behind the 'buzz' at these conferences? Did they subtly push doctors to experiment on their patients? Nothing would surprise me when it comes to pharmaceutical companies.